PublishedMarch 23, 2021 Category PARI News LAMIRA®, an eFlow® Technology nebulizer, expected to launch in Japan as a medical device for exclusive administration of ARIKAYCE® (amikacin liposome inhalation suspension)
PublishedMarch 1, 2021 Category Partner News Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial
PublishedJanuary 7, 2021 Category Partner News Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with MAC Lung Disease
PublishedJanuary 4, 2021 Category Publications Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub.
PublishedDecember 22, 2020 Category Partner News Polyphor receives approval to start first in human clinical trial of inhaled antibiotic murepavadin
